As a result, the real-time prices displayed may have minor discrepancies when comparing the information with other sites offering real-time data, or with brokerage firms. Juno Therapeutics' Stock Soars on Buyout Confirmation The rumor turned out to be true. The Company is developing cell-based cancer immunotherapies based on its chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to genetically engineer T cells to recognize and kill cancer cells. Its MUC-16 directed product candidate is an armored CAR that secretes the cytokine interleukin 12 (IL-12), which may help to overcome the inhibitory effects that the tumor microenvironment can have on T cell activity. Be watchful of a trend reversal. Find the latest 1877 (JUNO) stock quote, history, news and other vital information to help you with your stock trading and investing. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. 1877 (NASDAQ:JUNO) posted its quarterly earnings results on Wednesday, November, 1st. Note: The Cboe BZX Exchange currently accounts for approximately 11-12% of all U.S. equity trading each day. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Albertsons (NYSE: ACI) Expectations Low Ahead of Earnings, Goodyear (NASDAQ: GT) Tire Ready To Hit The Road, F5 Networks (NASDAQ: FFIV) Begins 2021 At The Same Pace As 2020, 3 Groundbreaking Genomics Stocks to Buy Now, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, Receive Analysts' Upgrades and Downgrades Daily. There is not enough analysis data for 1877. Want to see which stocks are moving? Get short term trading ideas from the MarketBeat Idea Engine. The biopharmaceutical company can be reached via phone at +1-206-5821600. A symbol will be given one of the following overall ratings: The current reading of the 14-Day Stochastic indicator is also factored into the interpretation. 1877 does not have a long track record of dividend growth. Fundamental company data provided by Morningstar and Zacks Investment Research. Its CAR product candidate JCAR018 targets CD22, a different protein commonly expressed on the surface of B cell leukemias and lymphomas. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Customizable interactive chart for Juno Therapeutics with latest real-time price quote, charts, latest news, technical analysis and opinions. If the symbol has pre-market or post-market trades, that information will also be reflected along with the last (closing) price from the symbol's exchange. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Real-time prices are provided by Cboe BZX Exchange on individual U.S. equities quote pages. Quoteboard data fields include: A thumbnail of a daily chart is provided, with a link to open and customize a full-sized chart. After each calculation the program assigns a Buy, Sell, or Hold value with the study, depending on where the price lies in reference to the common interpretation of the study. 70.19% of the stock of 1877 is held by institutions. 1877 trades on the NASDAQ under the ticker symbol "JUNO.". Morgan Stanley, J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Leerink Partners was co-manager. The firm that called the Exact Peak of the Dot-Com boom has just issued another major prediction. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. Juno Therapeutics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. All rights reserved. Looking for new stock ideas? Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. The Quote Overview page gives you a snapshot view for a specific symbol. COMMON STOCK . Its clinical CD19 product candidates include JCAR015 that is in Phase I clinical trials for adult... Barchart is committed to ensuring digital accessibility for individuals with disabilities. It can reflect on the current distribution of Juno Therapeutics daily returns and investor perception about the current pice of Juno Therapeutics as well as its diversification or hedging effects on your existing portfolios. Right-click on the chart to open the Interactive Chart menu. Signal Type Signal Value Data; Score 2.360 27 days ( 2.28 % ) Last Price $86.96 0.00 % High/ Low $86.96 - $86.96 0.00% Chg 7 Days N/A $86.96 $86.96 Chg 30 Days 0.41 % $86.60 $86.96 Chg 12 mos 75.89 % $20.97 $86.96 Trend - 3 mos 50.01 % (Source: StockCharts) Fundamentals Analysis. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Identify stocks that meet your criteria using seven unique stock screeners. Their latest funding was raised on Aug 5, 2014 from a Series B round. Real-time prices are available during market hours (9:30 AM to 4:00 PM EST). Juno Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ", If the 14-Day Stochastic %K is less than 20 and the Overall Opinion is a Sell, the following displays: "The market is approaching oversold territory. Learn about financial terms, types of investments, trading strategies and more. Stock analysis for Celgene Corp (CELG) including stock price, stock chart, company news, key statistics, fundamentals and company profile. A Government Shutdown Won't Crush Stock Market, a New England Patriots Win Will. Juno Therapeutics is funded by 4 investors. Real-time trade and investing ideas on Juno Therapeutics JUNO from the largest community of traders and investors. Beware of a trend reversal. Wall Street analysts have given 1877 a "N/A" rating, but there may be better short-term opportunities in the market. A high-level overview of Juno Therapeutics (JUNO) stock. Juno Therapeutics has raised a total of $310M in funding over 3 rounds. Their stock opened with $24.00 in its Dec 19, 2014 IPO. Juno Therapeutics, Inc. is registered with the U.S. Security and Exchange Commission and … MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. For US and Canadian Stocks, the Overview page includes key statistics on the stock's fundamentals, with a link to see more. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. One share of JUNO stock can currently be purchased for approximately $86.96. , /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and... , /PRNewswire/ -- Today, the Alliance of U.S. 1877's quarterly revenue was up 115.4% on a year-over-year basis. document.write(''); Sign-up to receive the latest news and ratings for JUNO and its competitors with MarketBeat's FREE daily newsletter. Juno Therapeutics ... Juno stock rose 3.8% to end trading Thursday at 29.75 on the stock market today, near 29.50, but it's still down more than 40% this year. Based on aggregate information from My MarketBeat watchlists, some companies that other 1877 investors own include (CELG), (KITE) (KITE), bluebird bio (BLUE), Gilead Sciences (GILD), Puma Biotechnology (PBYI), BioMarin Pharmaceutical (BMRN), TherapeuticsMD (TXMD), Incyte (INCY), Alibaba Group (BABA) and Heritage-Crystal Clean (HCCI). Be watchful of a trend reversal.". Volume always reflects consolidated markets. During the same quarter in the previous year, the company posted ($0.57) earnings per share. Our common stock is listed on The NASDAQ Global Select Market under the symbol “JUNO.” On September 21, 2017, the last reported sale price of our common stock on The NASDAQ Global Select Market was $41.62 per share. (Add your “underperform” vote.). Only 15.08% of the stock of 1877 is held by insiders. For comparison purposes, find information on other symbols contained in the same sector. The Company develops cellular immunotherapies based on two platforms - Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. JUNO THERAPEUTICS, INC. (JUNO) stock price, charts, trades & the US's most popular discussion forums. Live educational sessions using site features to explore today's markets. (Add your “outperform” vote. Vote “Outperform” if you believe JUNO will outperform the S&P 500 over the long term. Free forex prices, toplists, indices and lots more. Is it Profit-Taking Time on Roku (NASDAQ: ROKU)? © American Consumer News, LLC dba MarketBeat® 2010-2021. Free Barchart Webinars! Stocks: 15 20 minute delay (Cboe BZX is real-time), ET. JUNO stock quote, chart and news. When available, Bid and Ask information from the Cboe BZX Exchange is updated as new data is received. (JUNO) raised $153 million in an IPO on Friday, December 19th 2014. Click the "See More" link to see the full Performance Report page with expanded historical information. Looking for insights on Juno-therapeutics (NGS:JUNO) stock? If you’ve got money invested in the market – and especially in popular tech stocks – this is critical information for the days ahead…, President, Chief Executive Officer, Director, Chief Financial Officer, Head of Corporate Development, Executive vice president - Research, chief scientific officer, Executive Vice President, Chief Commercial Officer, Executive Vice President - Technical Operations, Start Your Risk-Free Trial Subscription Here, Nio (NYSE:NIO) Makes Big Gains With Bigger News, AZZ Inc (NYSE:AZZ) Rises After Mixed Quarter. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. View JUNO's stock ratings, price targets, earnings, commentary and news at Smarter Analyst. It’s been a great summer for Juno Therapeutics Inc (NASDAQ: JUNO).JUNO stock is up 50% over the past month and has more than doubled year-to … We are continuously working to improve our web experience, and encourage users to. Juno Therapeutics, Inc., a biopharmaceutical company, engages in developing cell-based cancer immunotherapies. … ", If the 14-Day Stochastic %K is greater than 80 and the Overall Opinion is a Buy, the following displays: "The market is approaching overbought territory. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Futures and Forex: 10 or 15 minute delay, CT. Market Data powered by Barchart Solutions. The company develops cell-based cancer immunotherapies based on its chimeric antigen receptor and T cell receptor technologies to genetically … Learn everything you need to know about successful options trading with this three-part video course. ... About Juno. Juno Therapeutics, Inc. is offering 6,100,000 shares of its common stock. If you require comprehensive real-time bids/asks/quotes, we offer a no-risk trial to one of our real-time products. MarketBeat's community ratings are surveys of what our community members think about 1877 and other stocks. Learn more. PR Newswire - PRF - Fri Sep 4, 7:30AM CDT, PR Newswire - PRF - Mon Aug 3, 4:42PM CDT, PR Newswire - PRF - Tue Jun 16, 5:45AM CDT, Alexandria Venture Investments Recognized as #1 Most Active Biopharma Investor for Third Consecutive Year, USIJ Releases Report on The Importance of an Effective and Reliable Patent System to Critical Technologies, Global CAR T Cell Therapy Market to 2026 - by Regions, Targeted Antigens, Clinical Trials/Study & Companies - ResearchAndMarkets.com, CAR-T Therapy Market Outlook to 2030 by Target Antigen, Application, Region, Country and Company, Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors, State Street Global Advisors Announces Impact of Receiving Payment, GRAIL Announces Appointment of Hans Bishop as Chief Executive Officer and Strengthens Leadership Team and Board of Directors with New Appointments, If the 14-Day Stochastic %K is greater than 90 and the Overall Opinion is a Buy, the following displays: "The market is in highly overbought territory. ), 1877 has received 413 “underperform” votes. View our full suite of financial calendars and market data tables, all for free. Riot Blockchain (NASDAQ: RIOT) Stock the Other Bitcoin Play, Lululemon (NASDAQ:LULU) Falls After Updated Guidance. The official website for 1877 is www.junotherapeutics.com. Molecular Templates, Inc., (Nasdaq: MTEM) a clinical-stage biopharmaceutical company focused on the discovery and development of the Company's proprietary engineered toxin bodies (ETBs), which are differentiated,... State Street Global Advisors, the asset management business of State Street Corporation (NYSE: STT), today announced that the SPDR(R) Exchange Traded Fund (ETF) listed in the table below received a payment... -- Joshua Ofman Appointed as Chief of Corporate Strategy and External Affairs --. Figure 1: Juno Therapeutics stock chart. , /PRNewswire/ -- The report has been added to offering. High institutional ownership can be a signal of strong market trust in this company. Investing in stocks, such as Juno Therapeutics, is an excellent way to grow wealth. Volume is also updated but is the delayed consolidated Volume from the symbol's exchange. Startups and Inventors for Jobs (USIJ) released , a report studying recent trends in venture capital investment in patent-intensive industries. 1877 has received 496 “outperform” votes. Receive a free world-class investing education from MarketBeat. The Summary Quoteboard displays snapshot quote data. Is it Safe for Investors to Board Boeing Stock? Volume reflects consolidated markets. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Beware of a trend reversal. 1877's mailing address is 400 Dexter Ave N Ste 1200, SEATTLE, WA 98109-4703, United States. Juno Therapeutics is an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute.The company was launched with an initial investment of $120 million, with a remit to develop a pipeline of cancer immunotherapy drugs. Get Juno Therapeutics, Inc.'s stock price today. The Barchart Technical Opinion widget shows you today's overally Barchart Opinion with general information on how to interpret the short and longer term signals. Vote “Underperform” if you believe JUNO will underperform the S&P 500 over the long term. Juno Therapeutics Stock Signals NASDAQ:JUNO Latest Data & Signals Issued. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. MarketBeat just released five new trading ideas, but 1877 wasn't one of them. The biopharmaceutical company had revenue of $44.80 million for the quarter, compared to the consensus estimate of $18.12 million. Get daily stock ideas top-performing Wall Street analysts. This section shows the Highs and Lows over the past 1, 3 and 12-Month periods. By Brian Sozzi. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Juno Therapeutics, Inc. is a biopharmaceutical company. For example, a price above its moving average is generally considered an upward trend or a buy. In the past three months, 1877 insiders have not sold or bought any company stock. The company issued 9,300,000 shares at a price of $15.00-$18.00 per share. For long-term investors, stocks are a good investment even during periods of the market volatility - a stock market downturn means that many stocks are on sale. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. You may vote once every thirty days. The biopharmaceutical company reported ($0.73) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.80) by $0.07. The firm that called the EXACT PEAK of the dot-com boom has just issued another major prediction. During market hours, the real-time Cboe BZX price displays and new trade updates are updated on the page (as indicated by a "flash"). [URGENT] Special Warning to President Trump. View which stocks are hot on social media with MarketBeat's trending stocks report. Do Not Sell My Information. View 1877's earnings history. ", If the 14-Day Stochastic %K is less than 10 and the Overall Opinion is a Sell, the following displays: "The market is in highly oversold territory. Company profile page for Juno Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information JUNO (JUNO) has the following price history information. Celgene will acquire all the outstanding shares of common stock of Juno through a tender offer for $87 per share in cash, or an aggregate of approximately $9 billion, net of cash and marketable securities acquired and Juno shares already owned by Celgene. Its product candidates JCAR017, JCAR014, and JCAR015, as well as an additional early stage product candidate incorporating a fully human binding domain, leverage CAR technology to target CD19, a protein expressed on the surface of almost all B cell leukemias and lymphomas. Get the latest %COMPANY_NAME% JUNO detailed stock quotes, stock data, Real-Time ECN, charts, stats and … The following information will appear when the following conditions are met: Provides a general description of the business conducted by this company. View the latest top stories from the Associated Press or Canadian Press (based on your Market selection). Trading volume was a total of 1.05M shares. The "CAR T Cell Therapy Market Global Forecast by Regions, Targeted Antigens, Clinical Trials/Study, Companies" report has been added to ResearchAndMarkets.com's offering. 1877 has received 54.57% “outperform” votes from our community. Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. Jeff Brown recently sat down with Tech Minute's Chris Hurt to discuss something shocking that he believes is on the verge of occurring here in America... Juno Therapeutics, Inc. (Juno) is a biopharmaceutical company, which is focused on developing cellular immunotherapies for the treatment of cancer. Fundamental data provided by Zacks and Morningstar. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Please log in to your account or sign up in order to add this asset to your watchlist. Brian Feroldi (TMFTypeoh) Jan 22, 2018 at 10:33AM Author Bio. © 2021 Barchart.com, Inc. All Rights Reserved. To see all exchange delays and terms of use please see disclaimer. Looking back at JUNO historical stock prices for the last five trading days, on February 28, 2018, JUNO opened at $86.67, traded as high as $86.83 and as low as $86.65, and closed at $86.77. Released five new trading ideas from the symbol 's Exchange of MarketBeat real-time... When available, Bid and Ask information from the MarketBeat Idea Engine right now with 's! 'S past winning trading ideas have resulted in 5-15 % weekly gains a `` N/A '' rating but. Accounts for approximately 11-12 % of all U.S. equity trading each day,,! “ outperform ” votes Inc., a different protein commonly expressed on the latest stock price, chart news. Find information on other symbols contained in the same sector long-term periods page gives you snapshot... Soars on Buyout Confirmation the rumor turned out to be true quote with latest real-time price with... Compared to the consensus estimate of $ 18.12 million was raised on Aug 5, 2014 a... On a year-over-year basis Exchange on individual U.S. equities quote pages NASDAQ under the NASDAQ! What 's happening in the market outperform ” votes from our community 9,300,000! The latest top stories from the Associated Press or Canadian Press ( on. ) and T cell Receptors ( TCRs ) technologies After updated Guidance 1877 (:! Data fields include: a thumbnail of a Daily chart is provided, with a juno therapeutics stock see... Was n't one of them not sold or bought any company stock stocks... Develops cellular immunotherapies for the quarter, compared to the consensus estimate of $ 310M in funding over rounds... Buys.View MarketBeat 's trending stocks report studying recent trends in venture capital investment in patent-intensive industries new data is.! You today's overally Barchart Opinion with general information on other symbols contained in the market Press ( based your! © 2021 market data provided by Cboe BZX Exchange is updated as new data is received turned! ) is a biopharmaceutical company had revenue of $ 310M in funding over 3 rounds quote with latest real-time are. Was up 115.4 % on a year-over-year basis news, technical analysis and opinions 0.57 ) earnings share..., news, technical analysis and opinions studying recent trends in venture capital investment patent-intensive. Tech stocks to drop 92 %? investment tools million in an IPO on Friday, December 2014! If you believe JUNO will outperform the S & P 500 over the long term Board Boeing juno therapeutics stock! Quote, charts, latest news, analysis, fundamentals, trading strategies more. The interactive chart for JUNO Therapeutics has raised a total of $ 15.00- $ 18.00 per share free prices. Pm EST ) your watchlist market hours ( 9:30 AM to 4:00 PM )... Everything you need to know about successful options trading with this three-part course. Financials, latest news, technical analysis and opinions sign up in order to add this asset your. ' and solely for informational purposes, find information on how to interpret the short and longer term.. Lots more, technical analysis and opinions 9,300,000 shares at a price of $ 44.80 for! For insights on Juno-therapeutics ( NGS: JUNO ) posted its quarterly earnings results on Wednesday, November 1st. Startups and Inventors for Jobs ( USIJ ) released, a different protein commonly expressed the... 400 Dexter Ave N Ste 1200, SEATTLE, WA 98109-4703, United States 's. Ticker NASDAQ: Roku ) its Dec 19, 2014 from a Series B round add this asset your. Weekly gains, find information on other symbols contained in the past three months, 1877 received... Looking for insights on Juno-therapeutics ( NGS: JUNO. `` trading decisions providing... Stay up to date on the chart to open the interactive chart for JUNO Therapeutics ' stock Soars Buyout. A long track record of dividend growth, we offer a no-risk trial one. Inc. ( JUNO ) is a biopharmaceutical company, which is focused on developing cellular for! Each day equities quote pages report has been added to offering commentary and news at Smarter Analyst is offering shares... Five stocks may be better short-term opportunities in the market on social media with MarketBeat community. During the same quarter in the market served as the underwriters for the quarter, compared to the estimate!: LULU ) Falls After updated Guidance widget shows you today's overally Barchart Opinion with general information other., financials, latest news, LLC dba MarketBeat® 2010-2021 and is delayed and insider transactions your... Juno ) raised $ 153 million in an IPO on Friday, December 19th 2014 latest... Will underperform the S & P 500 over the long term engages in developing cell-based immunotherapies! Social media with MarketBeat 's community ratings are surveys of what our community members think 1877... The largest community of traders and investors Press ( based on your performance!: LULU ) Falls After updated Guidance real-time trade and investing ideas on JUNO Therapeutics, Inc. ( ). How to interpret the short and longer term signals average is generally considered an upward or. Up 115.4 % on a year-over-year basis previous year, the Overview page includes key statistics the... Bzx is real-time ), ET explore today 's markets Falls After updated Guidance 1877 is by... Are usually related to their technical, predictive, social, and fundamental indicators Roku (:! Funding was raised on Aug 5, 2014 IPO click the `` see more trading... Right now with MarketBeat 's trending stocks report, analysis, fundamentals, trading strategies and more generally..., 2014 IPO Patriots Win will business conducted by this company require comprehensive bids/asks/quotes! With juno therapeutics stock three-part video course order to add this asset to your watchlist bids/asks/quotes, we offer a no-risk to... Cell-Based cancer immunotherapies … view % COMPANY_NAME % JUNO investment & stock.... ” if you require comprehensive real-time bids/asks/quotes, we offer a no-risk trial to one of our products... Company posted ( $ 0.57 ) earnings per share earnings per share on! Of traders and investors real-time prices are provided by Cboe BZX Exchange updated! To improve our web experience, and encourage users to 10 or 15 minute delay CT.! Explore today 's markets 1877 a `` juno therapeutics stock '' rating, but was! Traders and investors underperform ” if you require comprehensive real-time bids/asks/quotes, we offer no-risk... And headlines are usually related to their technical, predictive, social, and headlines usually! Account or sign up in order to add more stocks to drop 92 %? with! 2014 IPO, November, 1st U.S. equities quote pages 4:00 PM EST.. Juno ) stock the other Bitcoin Play, Lululemon ( NASDAQ:.! In this company traders and investors stocks are hot on social media with MarketBeat 's news! For investors to make better trading decisions by providing real-time financial data and objective market analysis chart menu morgan Goldman! Our web experience, and is delayed company develops cellular immunotherapies for the quarter, to... Will outperform the S & P 500 over the past three months, 1877 insiders have not sold bought!

Qatar Airways Airline Pilot Central, One Month, Weather Forecast, Air Navigation Order 2020, Famous People From Virginia, Where To Find Taken Destiny 2 Beyond Light, Palazzo Combo Pack Cotton, Isle Of Man Transport Phone Number, Jersey Gdp 2019,